Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS‐Induced Colitis via Mucus Barrier Protection
5 affiliations
- 1Pharmacology Department Federal University of Paraná Curitiba Paraná Brazil
- 2Biochemistry and Molecular Biology Department Federal University of Paraná Curitiba Paraná Brazil
- 3Faculty of Health Sciences of the Federal University of Rondonópolis Rondonópolis Mato Grosso Brazil
- 4BioPol, Pharmacy Department Federal University of Paraná Curitiba Paraná Brazil
- 5Genetic Department Federal University of Paraná Curitiba Paraná Brazil
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by weight loss, abdominal pain, diarrhoea and rectal bleeding. Polysaccharides have recognized protective and immunoregulatory effects in the gut. This study investigated BFS, a glucomannan extracted from bocaiuva, in dextran sulphate sodium (DSS)‐induced colitis. Male and female C57BL/6J mice received 3% DSS and BFS (1, 10, or 100 mg/kg, orally) for 7 days. Disease activity index (DAI) was monitored daily, while abdominal mechanical hypersensitivity and behavioural tests were assessed using von Frey filaments, elevated plus maze and nest‐building tests. Colons were collected for histological and biochemical analyses. BFS did not prevent DAI increase, but at 100 mg/kg reduced mechanical hypersensitivity. BFS prevented histopathological damage, inflammatory infiltration and alterations in mucosal architecture. BFS also reduced MPO, IL‐1β, TNF‐α, IFN‐γ and NFκB phosphorylation. Additionally, BFS preserved mucin content and MUC‐2 expression, with QCM‐D analysis corroborating its mucoadhesive potential. In males, BFS improved behavioural welfare parameters. Although BFS did not improve clinical signs, it preserved the mucus barrier and exerted anti‐inflammatory and analgesic effects, supporting its therapeutic potential in UC.
Related
- IκB kinase epsilon deficiency attenuates osteoarthritis-associated pain and synovitis with limited cartilage protection in complementary mouse models
- Atractylenolide III attenuates age-related vertebral bone loss by suppressing macrophage inflammation and osteoclastogenesis
- Pimpinella brachycarpa extract attenuates periodontal inflammation by modulating the PI3K/Akt–NF-κB signaling pathway
- Oral administration of Angiotensin-(1-7) included in hydroxypropyl β-cyclodextrin attenuates cardiac hypertrophy and inflammation in a mouse model of Takotsubo cardiomyopathy
- Previous malaria exposure attenuates monocyte-driven inflammation and correlates with modulation of the B cell response
BibTeX
@article{brito2026glucomannan,
title = {{Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS‐Induced Colitis via Mucus Barrier Protection}},
author = {Marcela S. C. Brito and Anderson K. Taporosky and Katlin S. Rech and Lucas B. S. Santos and Marcelo B. Gois and Larissa F. N. de Souza and Rilton A. de Freitas and Carolina A. B. Azevedo and Carolina Mathias and Lucimara M. C. Cordeiro and Maria F. P. Werner},
journal = {Clinical and Experimental Pharmacology \& Physiology},
year = {2026},
month = nov,
doi = {10.1111/1440-1681.70164},
url = {https://doi.org/10.1111/1440-1681.70164},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS‐Induced Colitis via Mucus Barrier Protection
AU - Marcela S. C. Brito
AU - Anderson K. Taporosky
AU - Katlin S. Rech
AU - Lucas B. S. Santos
AU - Marcelo B. Gois
AU - Larissa F. N. de Souza
AU - Rilton A. de Freitas
AU - Carolina A. B. Azevedo
AU - Carolina Mathias
AU - Lucimara M. C. Cordeiro
AU - Maria F. P. Werner
PY - 2026
DA - 2026/11/08
JO - Clinical and Experimental Pharmacology & Physiology
DO - 10.1111/1440-1681.70164
UR - https://doi.org/10.1111/1440-1681.70164
AB - Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by weight loss, abdominal pain, diarrhoea and rectal bleeding. Polysaccharides have recognized protective and immunoregulatory effects in the gut. This study investigated BFS, a glucomannan extracted from bocaiuva, in dextran sulphate sodium (DSS)‐induced colitis. Male and female C57BL/6J mice received 3% DSS and BFS (1, 10, or 100 mg/kg, orally) for 7 days. Disease activity index (DAI) was monitored daily, while abdominal mechanical hypersensitivity and behavioural tests were assessed using von Frey filaments, elevated plus maze and nest‐building tests. Colons were collected for histological and biochemical analyses. BFS did not prevent DAI increase, but at 100 mg/kg reduced mechanical hypersensitivity. BFS prevented histopathological damage, inflammatory infiltration and alterations in mucosal architecture. BFS also reduced MPO, IL‐1β, TNF‐α, IFN‐γ and NFκB phosphorylation. Additionally, BFS preserved mucin content and MUC‐2 expression, with QCM‐D analysis corroborating its mucoadhesive potential. In males, BFS improved behavioural welfare parameters. Although BFS did not improve clinical signs, it preserved the mucus barrier and exerted anti‐inflammatory and analgesic effects, supporting its therapeutic potential in UC.
SN - 0305-1870
SN - 1440-1681
ER -